Mesenchymal stem cells promote colorectal cancer progression through AMPK/mTOR-mediated NF-κB activation

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Wu, Xiao Bing ^a,b   Liu, Yang ^d   Wang, Gui Hua ^b   Xu, Xiao ^c   Cai, Yang ^b   Wang, Hong Yi ^b   Li, Yan Qi ^b   Meng, Hong Fang ^b   Dai, Fu ^a   Jin, Ji De ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^c Armed Police Army General Hospital   (China)

^d GUIYANG COLLEGE OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CONDITIONED MEDIUM; CYTOKINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TARGET OF RAPAMYCIN KINASE;

ANIMAL; APOPTOSIS; CANCER STEM CELL; CELL CYCLE; CELL MOTION; CELL PROLIFERATION; CELL TRANSFORMATION; COLORECTAL TUMOR; CONDITIONED MEDIUM; DISEASE COURSE; DRUG EFFECTS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; MESENCHYMAL STROMA CELL; METABOLISM; MOUSE; PATHOLOGY; PHARMACOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; CULTURE MEDIA, CONDITIONED; CYTOKINES; DISEASE PROGRESSION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MICE; NEOPLASTIC STEM CELLS; NF-KAPPA B; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84958955074     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21420     Document Type: Article

References (40)

1. Huang, S., Wu, Y., Gao, D., Fu, X. Paracrine action of mesenchymal stromal cells delivered by microspheres contributes to cutaneous wound healing and prevents scar formation in mice. Cytotherapy 17, 922-931 (2015).
2. Hanahan, D., Coussens, L. M. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer cell 21, 309-322 (2012).
3. Rodriguez, R., Rubio, R., Menendez, P. Modeling sarcomagenesis using multipotent mesenchymal stem cells. Cell Res 22, 62-77 (2012).
4. Tsai, K. S. et al. Mesenchymal stem cells promote formation of colorectal tumors in mice. Gastroenterology 141, 1046-1056 (2011).
5. De Boeck, A. et al. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling. Gut 62, 550-560 (2013).
6. Mele, V. et al. Mesenchymal stromal cells induce epithelial-to-mesenchymal transition in human colorectal cancer cells through the expression of surface-bound TGF-beta. Int J Cancer. 134, 2583-2594 (2014).
7. Chen, D. et al. Paracrine factors from adipose-mesenchymal stem cells enhance metastatic capacity through Wnt signaling pathway in a colon cancer cell co-culture model. Cancer Cell Int 15, 42 (2015).
8. Francipane, M. G., Lagasse, E. mTOR pathway in colorectal cancer: an update. Oncotarget 5, 49-66 (2014).
9. He, K., Zheng, X., Li, M., Zhang, L., Yu, J. mTOR inhibitors induce apoptosis in colon cancer cells via CHOP-dependent DR5 induction on 4E-BP1 dephosphorylation. Oncogene (2015).
10. Lee, Y. K. et al. Suppression of mTOR via Akt-dependent and-independent mechanisms in selenium-treated colon cancer cells: involvement of AMPKalpha1. Carcinogenesis 31, 1092-1099 (2010).
11. Ahmed, M., Kundu, G. C. Osteopontin selectively regulates p70S6K/mTOR phosphorylation leading to NF-kappaB dependent AP-1-mediated ICAM-1 expression in breast cancer cells. Mol Cancer 9, 101 (2010).
12. Li, X. et al. Modulation of gene expression regulated by the transcription factor NF-kappaB/RelA. J Biol Chem 289, 11927-11944 (2014).
13. Tamatani, T. et al. Enhanced IkappaB kinase activity is responsible for the augmented activity of NF-kappaB in human head and neck carcinoma cells. Cancer Lett 171, 165-172 (2001).
14. Cichon, M. A., Radisky, D. C. ROS-induced epithelial-mesenchymal transition in mammary epithelial cells is mediated by NF-kBdependent activation of Snail. Oncotarget 5, 2827-2838 (2014).
15. Zhang, Y. et al. Bone marrow mesenchymal stromal cells affect the cell cycle arrest effect of genotoxic agents on acute lymphocytic leukemia cells via p21 down-regulation. Ann Hematol 93, 1499-1508 (2014).
16. Luu, N. T. et al. Crosstalk between mesenchymal stem cells and endothelial cells leads to downregulation of cytokine-induced leukocyte recruitment. Stem cells 31, 2690-2702 (2013).
17. Liu, Y. et al. Effect of serum choice on replicative senescence in mesenchymal stromal cells. Cytotherapy 17, 874-884 (2015).
18. Xu, C., Lin, L., Cao, G., Chen, Q., Shou, P. Interferon-alpha-secreting mesenchymal stem cells exert potent antitumor effect in vivo. Oncogene 33, 5047-5052 (2014).
19. Reed, S., Li, H., Li, C., Lin, J. Celecoxib inhibits STAT3 phosphorylation and suppresses cell migration and colony forming ability in rhabdomyosarcoma cells. Biochem Biophys Res Commun 407, 450-455 (2011).
20. Motz, G. T. et al. Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors. Nat Med 20, 607-615 (2014).
21. Johansson, A. C. et al. Cancer-associated fibroblasts induce matrix metalloproteinase-mediated cetuximab resistance in head and neck squamous cell carcinoma cells. Mol Cancer Res 10, 1158-1168 (2012).
22. Chen, F. et al. Mesenchymal stem cells induce granulocytic differentiation of acute promyelocytic leukemic cells via IL-6 and MEK/ERK pathways. Stem Cells Dev 22(13), 1955-67 (2013).
23. Kolosa, K., Motaln, H., Herold-Mende, C., Korsic, M., Lah, T. T. Paracrine effects of mesenchymal stem cells induce senescence and differentiation of glioblastoma stem-like cells. Cell Transplant 24, 631-644 (2015).
24. Lozito, T. P., Tuan, R. S. Endothelial and cancer cells interact with mesenchymal stem cells via both microparticles and secreted factors. J Cell Mol Med 18, 2372-2384 (2014).
25. Kansy, B. A. et al. The bidirectional tumor-mesenchymal stromal cell interaction promotes the progression of head and neck cancer. Stem Cell Res Ther 5, 95 (2014).
26. Katanov, C. et al. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-alpha and the NF-kappaB pathway. Stem Cell Res Ther 6, 87 (2015).
27. Chowdhury, R. et al. Cancer exosomes trigger mesenchymal stem cell differentiation into pro-angiogenic and pro-invasive myofibroblasts. Oncotarget 6, 715-731 (2015).
28. Liu, S. et al. Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res 71, 614-624 (2011).
29. Arno, A. I. et al. Effect of human Wharton's jelly mesenchymal stem cell paracrine signaling on keloid fibroblasts. Stem Cells Transl Med. 3, 299-307 (2014).
30. De Simone, V. et al. Th17-type cytokines, IL-6 and TNF-alpha synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth. Oncogene 34, 3493-3503 (2015).
31. Kansy B. A. et al. The bidirectional tumor-mesenchymal stromal cell interaction promotes the progression of head and neck cancer. Stem Cell Res Ther 5(4), 95 (2014).
32. Teng, I. W. et al. Targeted methylation of two tumor suppressor genes is sufficient to transform mesenchymal stem cells into cancer stem/initiating cells. Cancer Res 71, 4653-4663 (2011).
33. Hossain, A. et al. Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway. Stem cells 33, 2400-2415 (2015).
34. Johnson, S. M. et al. Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer. J Am Coll Surg 210, 767-776, 776-768 (2010).
35. Faller, W. J. et al. mTORC1-mediated translational elongation limits intestinal tumour initiation and growth. Nature 517, 497-500 (2015).
36. Ou, J. et al. Loss of abhd5 promotes colorectal tumor development and progression by inducing aerobic glycolysis and epithelialmesenchymal transition. Cell Rep 9, 1798-1811 (2014).
37. Shin, D. J. et al. 20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol suppresses UV-Induced MMP-1 expression through AMPKmediated mTOR inhibition as a downstream of the PKA-LKB1 pathway. J Cell Biochem 115, 1702-1711 (2014).
38. Dan, H. C. et al. Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK. Genes Dev 22, 1490-1500 (2008).
39. Vinciguerra, M. et al. PTEN down-regulation by unsaturated fatty acids triggers hepatic steatosis via an NF-kappaBp65/mTORdependent mechanism. Gastroenterology 134, 268-280 (2008).
40. Cooks, T. et al. Mutant p53 prolongs NF-kappaB activation and promotes chronic inflammation and inflammation-associated colorectal cancer. Cancer cell 23, 634-646 (2013).